Your questions about brain health technology, answered honestly.

By David Johansson | Neurofeedback Practitioner & Certified Brain Health Coach

Disclosure: Some links on this page are affiliate links, which means I may earn a small commission if you make a purchase through them. This comes at no additional cost to you. I only recommend products I have personally evaluated, used, or believe in based on my professional experience. My opinions are my own, and affiliate relationships never influence my assessments or recommendations.

On this page: PEMF Therapy (10 questions) | Photobiomodulation (coming soon) | Long COVID & Brain Health (coming soon)

PEMF Therapy (Pulsed Electromagnetic Field Therapy)

Q1. What is PEMF therapy and how does it work?

PEMF stands for pulsed electromagnetic field therapy. It’s a non-invasive approach that delivers low-frequency electromagnetic pulses to the body, where they interact with your cells’ natural electrical activity. At the cellular level, these pulses support membrane potential — the voltage difference across your cell walls that drives nutrient transport, waste removal, and cellular communication. When cells are stressed, injured, or chronically inflamed, that voltage drops. PEMF helps restore it.

Think of it this way: your cells run on electrical charge the way a battery runs on voltage. PEMF doesn’t add anything foreign to your body — it delivers an electromagnetic signal that supports what your cells are already trying to do. The therapy has been used in clinical settings for decades, most notably for bone fracture healing and post-surgical recovery, and specific PEMF devices have received FDA clearance for those applications. Consumer devices designed for home use — including wearables, mats, and portable units — have expanded access significantly, though it’s important to understand that most are classified as “general wellness” devices, not FDA-cleared for specific medical conditions.

Q2. How much do PEMF devices cost for home use?

Home PEMF devices range widely — from roughly $200 for compact wearables to $5,000+ for full-body mat systems. The price differences reflect intensity, coverage area, protocol options, and build quality.

At the entry level, pocket-sized wearable devices like the Resona Vibe run around $299 and deliver targeted PEMF through preset protocols. Mid-range options ($500–$1,500) typically include larger applicators or mat designs that cover more body area. High-end systems from companies like Bemer or Pulse PEMF can run several thousand dollars and are often marketed to practitioners and clinics as well as home users.

The question isn’t just “how much does it cost?” — it’s “what am I getting for that cost?” A more expensive device doesn’t automatically mean better results. What matters is whether the device delivers appropriate frequencies and intensities for your specific needs, and whether you’ll actually use it consistently. A $3,000 mat that sits in a closet is a worse investment than a $299 portable unit you use daily.

Q3. Is the Resona Vibe worth the price?

This is one of the most common questions I get, and the honest answer is: it depends on what you’re looking for and what you’re comparing it to.

The Resona Vibe is a pocket-sized PEMF device priced at $299. It weighs 75 grams — about the weight of a deck of cards — and you wear it in a shirt pocket or on a lanyard. It comes with 60 core protocols and 70 expansion protocols covering pain, inflammation, sleep, stress, focus, and recovery. It offers a frequency range up to 1,000 Hz with a maximum listed field strength of 900 microtesla, adjustable across 10 intensity levels. Battery life is 5–8 hours depending on intensity. No app required, no subscription.

What makes it worth considering: portability and protocol variety. Most competing devices at this price point offer far fewer preset programs and are less portable. The Vibe is one of the few devices you can realistically wear throughout your day — while working, cooking, or walking — which matters because PEMF benefits come from consistent use over time, not single sessions.

What it won’t do: replace a high-intensity clinical PEMF system. If you need deep-tissue penetration for a serious musculoskeletal condition, a more powerful mat or applicator system may serve you better. The Vibe operates at lower intensities than clinical-grade systems, which is appropriate for its design purpose — daily wellness support and targeted protocol delivery — but it’s important to match the tool to the goal. My take: for someone entering PEMF therapy for the first time, or for someone who wants a portable complement to a clinical-grade system, the Resona Vibe represents strong value at its price point. The 30-day money-back guarantee also reduces the risk of trying it.

Q4. Are there side effects or risks with PEMF therapy?

PEMF therapy has a strong overall safety profile. It’s non-invasive, drug-free, and most users experience no significant side effects. That said, some people — particularly during their first few sessions — report temporary and mild effects including light fatigue, tingling, warmth at the application site, or a brief increase in discomfort before improvement. These typically resolve within the first week or two as the body adjusts.

The more important conversation is about contraindications — situations where PEMF should be avoided entirely or used only under medical supervision:

Pacemakers and implanted electronic devices — electromagnetic fields can interfere with device function. This is a hard stop.

Pregnancy — many practitioners recommend avoiding PEMF for the entire pregnancy due to limited human safety data. While the first trimester is the most developmentally sensitive period, the precautionary guidance extends to the full term given the absence of controlled studies in pregnant populations.

Organ transplant recipients — PEMF may stimulate immune function, which could conflict with immunosuppressant medications.

Active bleeding or bleeding disorders — PEMF can increase circulation, which is generally beneficial but problematic when bleeding is present.

Ferromagnetic implants — implants made from magnetic metals can interact with the electromagnetic field.

If you have any of these conditions, consult your physician before using any PEMF device. And if you’re on blood-thinning medications or managing an active cancer diagnosis, that conversation with your doctor is essential — not optional.

Q5. Why isn’t my PEMF device helping? Common mistakes people make.

You bought a PEMF device. You’ve been using it. And nothing seems to be changing. That’s frustrating — especially when you invested real money based on real research that said this should work.

Here’s what I’ve seen most often when someone isn’t getting results:

They’re not using it consistently. PEMF is a cumulative therapy. Single sessions or occasional use rarely produce meaningful change. Most research protocols involve daily use over weeks, not sporadic sessions. If you’re using your device once or twice a week, you’re not replicating the conditions under which the positive research results were generated.

The intensity or frequency is wrong for the condition. Not all PEMF signals are the same. A protocol designed for relaxation and sleep isn’t going to address acute musculoskeletal pain effectively, and vice versa. This is one reason devices with multiple preset protocols — rather than a single fixed output — offer more flexibility. But you still need to select the right program for what you’re trying to address.

They’re dehydrated. Because your tissues are mostly water and electrolytes, good hydration likely supports optimal response to PEMF, and many practitioners see better outcomes when clients are well-hydrated. Hydrating well before and during PEMF sessions is a basic step that can make a real difference.

Combine Protocols. Sometimes I will combine protocols for more effective results. For example, when I was dealing with allergies I ran the Allergy setting followed by General Inflammation.

Expectations don’t match the evidence. PEMF is a tool, not a cure. It supports the body’s natural repair and regulation processes. If you’re dealing with a chronic condition that has multiple contributing factors — poor sleep, high stress, nutritional deficiencies, unresolved inflammation — PEMF alone may not be enough. It works best as part of an integrated approach, not as a standalone miracle.The device itself may not be delivering what it claims. Not all consumer PEMF devices are created equal. Some budget devices don’t actually produce measurable electromagnetic output at the frequencies they advertise. If you’re skeptical about whether your device is working, a simple gaussmeter test can verify output.

Q6. PEMF vs. red light therapy (PBM) — what’s the difference and which do I need?

This is one of the most common questions in the wellness technology space, and the short answer is: they work through completely different mechanisms, target different biological pathways, and are often more complementary than competitive.

PEMF delivers low-frequency electromagnetic pulses that interact with your cells’ electrical charge. Its primary effects are on membrane potential, ion transport, circulation, and the nitric oxide signaling cascade. PEMF’s strongest research base is in pain management, bone healing, inflammation reduction, and soft tissue recovery. PEMF fields can penetrate more deeply and affect a broader volume of tissue around the applicator than light-based therapies, which are limited by optical penetration depth.

Photobiomodulation (PBM) uses specific wavelengths of red and near-infrared light to stimulate a photoreceptor on your mitochondria called cytochrome c oxidase. This triggers a cascade that increases ATP production, reduces oxidative stress, and modulates inflammation. PBM’s strongest research base is in brain health (traumatic brain injury, neurodegeneration, long COVID brain fog), wound healing, and chronic pain. Light-based therapy is limited by optical penetration depth, which is why device design (wavelength, power density, pulsing frequency) matters enormously for brain-targeted applications.

When do you need one vs. the other? If your primary concern is musculoskeletal pain, inflammation, or general recovery support, PEMF is a strong starting point. If you’re focused on brain health, cognitive function, or neurological recovery, PBM — particularly transcranial PBM — has a more targeted evidence base. For many of the people I work with, the answer isn’t either/or. These modalities address different layers of the same problem, and combining them as part of an integrated protocol often produces better outcomes than either one alone.

Q7. How does the Resona Vibe compare to other home PEMF devices?

The home PEMF market has expanded rapidly, and devices vary significantly in design philosophy, intensity, portability, and price. Here’s how the Resona Vibe fits in the landscape:

Vs. PEMF mats (Bemer, HealthyLine, iMRS): Mat systems deliver whole-body coverage and typically operate at higher intensities. They’re designed for lying-down sessions of 8–30 minutes. The Vibe is a different category entirely — it’s a wearable you keep on throughout your day, delivering targeted protocols while you go about your life. Mats are generally better for whole-body systemic support; the Vibe is better for consistent, portable, protocol-specific delivery. Mats also cost significantly more — most start around $1,000 and go up to $6,000+.

Vs. other wearable PEMF (FlexPulse, NeoRhythm): The FlexPulse is a comparable portable device but offers fewer preset protocols. NeoRhythm is a headband-style device focused specifically on brain-related protocols (sleep, focus, relaxation). The Vibe’s 130 total protocols (60 core + 70 expansion) give it the broadest program library in the portable category, and its frequency range (up to 1,000 Hz) is wider than most competitors in this price class.

Vs. DNA Vibe Jazz Band: The Jazz Band combines PEMF with red and near-infrared light and micro-vibration in a wearable format, making it a multimodal device rather than a pure PEMF unit. It’s designed primarily for localized pain and recovery. The Vibe is PEMF-only but offers far more protocol variety and a broader frequency range.

No single device is “best” for everyone. The right choice depends on your goals, your lifestyle, and how you’ll realistically integrate it into your routine.

Q8. What does the research say about PEMF for pain and recovery?

The evidence base for PEMF in pain management is one of the stronger areas in the field. A 2025 multi-center randomized controlled trial evaluating PEMF for joint and soft tissue pain found that the PEMF group experienced a 36% reduction in pain scores over 60 days, compared to 10% in the standard-care-only group. Over half of PEMF users reduced or discontinued pain medication during the study period.

Systematic reviews have also shown positive results for PEMF in osteoarthritis — particularly knee osteoarthritis — with consistent improvements in pain and physical function scores. A 2026 systematic review of randomized trials specifically evaluating PEMF for soft tissue injuries in the foot and ankle found benefits in both short-term pain and longer-term functional recovery.

For bone healing, PEMF has the longest track record. Specific PEMF devices have been FDA-cleared for non-union fractures and post-surgical bone repair, and the research supporting those applications goes back decades.

Where the evidence is more mixed: conditions with less direct musculoskeletal pathology — depression, fibromyalgia, general “wellness” claims. There’s preliminary research, but not the kind of rigorous, replicated trial data that exists for pain and orthopedic applications. When someone tells you PEMF “treats” 40 different conditions, that’s marketing outrunning the evidence. The honest picture is that PEMF has strong support for pain, inflammation, and bone healing; promising but earlier-stage evidence for neurological and broader applications; and insufficient evidence for many of the claims you’ll see on device company websites.

Q9. What’s the best PEMF device for home use in 2026?

There’s no single “best” PEMF device — there’s the best device for your situation. That’s not a dodge. It’s the reality of a product category where the devices vary dramatically in what they do and who they’re designed for.

Here’s how I’d frame the decision:

If portability and daily use matter most: A wearable device like the Resona Vibe ($299) gives you the most protocol variety in the smallest form factor. You’ll actually use it because it fits into your life rather than requiring you to set aside a dedicated session. This is the category I’d point most first-time PEMF users toward.

If you want whole-body coverage for systemic support: A PEMF mat system is the right category. Expect to spend $1,000–$6,000 depending on the brand and features. These are session-based — you lie on them for a set period — so compliance depends on your willingness to build that into your daily routine.

If you want multimodal therapy (PEMF + light): The DNA Vibe Jazz Band combines PEMF with red and near-infrared light in a wearable. It’s a localized tool, not a whole-body system, but it addresses two modalities in one device.

If your focus is brain health specifically: PEMF alone may not be your best starting point. Transcranial PBM devices have a stronger and more targeted evidence base for brain applications. That said, PEMF can complement a brain-focused protocol as part of a broader approach.

What I’d avoid: any device that claims to treat everything, cites only animal studies as proof, or charges a premium based on marketing rather than engineering. Look for devices with transparent specifications (frequency range, intensity, waveform), a reasonable return policy, and ideally some connection to published research — even if the research used a different device, the parameters should be comparable.

Q10. Who should (and shouldn’t) use PEMF therapy?

Good candidates for PEMF: People dealing with chronic or acute musculoskeletal pain, post-surgical recovery, soft tissue injuries, inflammation-related conditions, or general recovery support. Athletes and active individuals use PEMF for performance recovery. People with sleep issues or high stress may benefit from specific frequency protocols designed for relaxation and nervous system regulation. PEMF is also widely used in veterinary and equine applications.

People who should proceed with caution (consult your physician first): Those with active cancer diagnoses (PEMF can stimulate cellular activity, which requires careful consideration in the context of cancer treatment), people on blood-thinning medications, anyone with a history of seizures, and those managing hypotension.

People who should not use PEMF: Anyone with a pacemaker, defibrillator, or other implanted electronic medical device. Anyone with ferromagnetic implants. Pregnant women — many practitioners recommend avoiding PEMF for the entire pregnancy due to limited human safety data, even though the first trimester is the most sensitive period. Organ transplant recipients on immunosuppressant medications. Anyone with active, uncontrolled bleeding.

These aren’t limitations of PEMF as a therapy — they’re responsible boundaries that apply to any intervention that affects the body’s electrical and circulatory systems. A good practitioner or a good device company will tell you this upfront. If they don’t mention contraindications at all, that’s a red flag about their credibility.

Photobiomodulation (PBM / Red & Near-Infrared Light Therapy)

Q1. What is photobiomodulation and how is it different from red light therapy panels?

Photobiomodulation (PBM) is the use of specific wavelengths of red and near-infrared light to produce a biological effect at the cellular level. The light is absorbed by a photoreceptor on your mitochondria called cytochrome c oxidase, which triggers a cascade: increased ATP production (cellular energy), reduced oxidative stress, modulated inflammation, and downstream signaling that supports repair and neuroplasticity.

The term "red light therapy" has become a catch-all that lumps together very different technologies under one umbrella — and that creates confusion. A full-body LED panel designed for skin health, muscle recovery, and general wellness is not the same device as a transcranial PBM helmet engineered to deliver specific wavelengths through the skull at specific pulsing frequencies to reach brain tissue. They share the same mechanism at the cellular level, but the engineering, the dose delivery, and the target tissue are completely different.

Here's the distinction that matters most: a skin panel operates on surface tissue that light reaches easily. A transcranial device has to solve for the fact that photons must pass through skin, bone, and cerebrospinal fluid before reaching cortical neurons — and every layer absorbs and scatters the light. That's why wavelength selection (typically 810nm near-infrared for brain applications), power density, pulsing frequency, and applicator placement all matter enormously for brain-targeted PBM. Grouping these devices together under "red light therapy" obscures the differences that determine whether the therapy actually works for a given application.

-----

Q2. How much do PBM devices cost — from panels to transcranial helmets?

PBM device pricing spans a wide range depending on what the device is designed to do.

Full-body or panel-style devices for skin, muscle recovery, and general wellness typically run $300–$1,500 for consumer models, with professional-grade panels climbing higher. These deliver red (typically 630–660nm) and near-infrared (810–850nm) wavelengths across a broad surface area.

Transcranial PBM devices — helmets and headsets designed to deliver light to brain tissue — start around $1,500 and can exceed $3,000. The Vielight Neuro Gamma, used in several of the strongest clinical studies, falls in this range. The Neuronic Neuradiant 1070 represents another approach at a different price point. The iMediSync iSyncWave sits at the higher end, offering QEEG-guided PBM with real-time brain mapping — a very different proposition from a fixed-protocol helmet.

Intranasal PBM devices — which deliver light through the nasal cavity to reach brain regions via vascular proximity — are the most affordable category, with some models starting under $500.

The price question that matters most isn't "how much does it cost?" but "does this device deliver the wavelength, power density, and pulsing parameters supported by the research for my specific goal?" A $400 panel is excellent value for skin and muscle applications. It's not an appropriate tool for brain health, regardless of what the marketing implies. A $2,500 transcranial device is a significant investment — but if the engineering matches the evidence base and you use it consistently, the cost-per-session over its lifespan is modest compared to ongoing clinical treatments.

[AFFILIATE NOTE: Vielight affiliate — code "Greymatters". Neuronic affiliate — code "TotalNeuroSolutions".]

You can choose different PBM devices based on your need and available resources. Vielight has the most options and is constantly doing research. Their MIP device is lower cost and simple to use. Getting light intranasally can be beneficial for viruses as well as providing light therapy to the brain through the base of the skull. A Neuronic helmet is very convenient to use, and you can easily be reading or watching TV while doing your session. The Jazz Band is multi functional, for both physical recovery and brain health. My advice is to start with the device that you will use, and then you can upgrade as time and money allows.

-----

Q3. Is a transcranial PBM device worth the investment for brain health?

This is a question I take personally — as someone with at least six concussions who uses transcranial PBM as part of my own recovery protocol.

The honest answer: the evidence is now stronger than it's ever been, but "worth it" depends on your situation. Transcranial PBM devices represent a significant upfront cost. What you're buying is access to a modality that the research increasingly supports for brain health applications — with the caveat that the research is still maturing and the optimal protocols aren't fully established.

Here's what the evidence supports as of 2025–2026: A neuroprotection study in NCAA football players showed that regular transcranial PBM during a competitive season stabilized brain markers that deteriorated in the sham group. A sham-controlled pilot trial for long COVID brain fog showed cognitive improvements, particularly in participants under 45. Randomized trials in mild traumatic brain injury have shown improvements in working memory, post-concussion symptoms, and PTSD scores. And a 2025 expert panel issued the first clinical practice guidelines confirming PBM as a safe treatment modality for adults.

What the evidence doesn't yet support: guaranteed results for every person, every condition, at every age. The dose-response relationship is complex, age-related factors affect how much light reaches the brain, and sample sizes in brain studies are still modest.

My perspective: if you're dealing with a brain health concern — TBI recovery, cognitive decline, persistent brain fog — and you've already addressed the fundamentals (sleep, nutrition, stress, inflammation), a transcranial PBM device is one of the most promising tools available. It's not a replacement for clinical care. It's a complement to it. And the 2025–2026 evidence base has moved it from "interesting but speculative" to "guideline-supported with active research expanding the applications."

[AFFILIATE NOTE: Vielight disclosure applies]

-----

Q4. Can you overdo light therapy? Understanding the biphasic dose response.

Yes — and this is one of the most important concepts in PBM that most marketing ignores entirely.

PBM follows what's called a biphasic (or Arndt-Schulz) dose response: too little light energy does nothing measurable, a moderate dose produces benefit, and too much can actually inhibit the biological processes you're trying to support. The dose-response curve looks like an inverted U — benefit rises with increasing dose up to an optimal window, then declines and can become counterproductive.

This means "more power" and "longer sessions" are not selling points. They're risk factors for overdosing. If a device manufacturer or influencer tells you that their panel is superior because it has the highest irradiance or that you should run sessions longer "for maximum benefit," they're contradicting the fundamental photobiology that makes PBM work.

The optimal dose depends on the target tissue, the wavelength, the power density at the tissue surface, and the total energy delivered (measured in joules per square centimeter). For transcranial applications, the calculation becomes especially complex because you have to account for how much light actually reaches the brain after passing through skin, skull, and cerebrospinal fluid. A dose that's optimal at the skin surface may be insufficient at the cortex — or a dose that seems reasonable on paper may overshoot what the tissue can productively absorb.

This is one of the reasons working with a practitioner who understands PBM dosimetry — rather than simply following a device manufacturer's default settings — can make a meaningful difference in outcomes.

-----

Q5. Is photobiomodulation safe? What are the actual risks?

PBM has a strong safety profile. In 2025, a panel of 21 international experts issued the first formal clinical practice guidelines for PBM, confirming it as a safe treatment modality for adult patients and concluding that red light PBM does not induce DNA damage.

The most commonly reported side effects are mild and transient: temporary headache, mild nausea, or a brief sense of fatigue after brain-targeted sessions. These are generally attributed to the neurobiological response itself — increased blood flow, metabolic activation, and neuroplastic changes — rather than to harm being caused. They typically resolve within hours and often diminish with continued use.

The more serious consideration is overdosing, which connects directly to the biphasic dose response. Using too much energy, too frequently, or at inappropriate parameters can inhibit rather than support biological function. This isn't dangerous in the way a pharmaceutical overdose is dangerous — but it can stall your progress or produce discomfort that undermines compliance.

Contraindications and cautions for PBM:

• Active retinal disease or direct eye exposure: Never shine NIR light directly into the eyes. Transcranial devices are designed to avoid direct retinal exposure, but panel users should wear appropriate eye protection.

• Photosensitizing medications: Some medications (certain antibiotics, retinoids, and others) increase sensitivity to light. Consult your physician if you're taking any photosensitizing drugs.

• Active cancer at the treatment site: PBM stimulates cellular metabolism, which requires careful consideration in the context of active malignancy. This is a conversation for your oncologist.

• Pregnancy: Many practitioners recommend avoiding PBM — particularly transcranial applications — during pregnancy due to limited human safety data. While the first trimester carries the most developmental sensitivity, the precautionary guidance extends to the full term given the absence of controlled studies in pregnant populations.

• Epilepsy or seizure disorders: Pulsed-frequency PBM devices (particularly those pulsing at 40 Hz) require caution in individuals with photosensitive epilepsy.

These are not reasons to fear PBM. They're reasons to use it with the same informed, individualized approach you'd apply to any intervention affecting brain and body function.-----

Q6. Transcranial PBM vs. full-body red light panels — which one do I need?

These are fundamentally different tools designed for different purposes, and the confusion between them is one of the biggest problems in the "red light therapy" space.

Full-body panels deliver red and near-infrared light across a broad surface area. They're effective for skin health, muscle recovery, wound healing, and general anti-inflammatory support. The light reaches surface and near-surface tissues easily. These devices are well-suited for musculoskeletal applications, athletic recovery, and aesthetic purposes. They do not deliver meaningful doses of light to brain tissue — the optical penetration depth through the skull limits what a panel positioned in front of your body can achieve for neurological applications.

Transcranial PBM devices are engineered specifically to overcome the challenge of delivering light energy through the skull to brain tissue. They use wavelengths optimized for tissue penetration (typically 810nm NIR), specific pulsing frequencies (often 40 Hz, which corresponds to gamma brainwave activity), and applicator placements targeting key brain regions or networks. Some also include intranasal components that deliver light to brain areas accessible through the nasal vasculature.

The bottom line: If your goal is skin health, muscle recovery, or general wellness — a panel is appropriate and cost-effective. If your goal is brain health, cognitive recovery, neuroprotection, or addressing neurological symptoms — a transcranial device is the right category. If someone tells you their full-body panel "helps brain fog" based on the general PBM mechanism, they're conflating device categories in a way that the evidence doesn't support.

-----

Q7. How do Vielight, Neuronic, and other transcranial PBM devices compare?

The transcranial PBM device market is still relatively small compared to consumer panels, but there are meaningful differences between the major options. Here's how I'd frame the landscape:

Vielight (Neuro Gamma / Neuro Alpha / Neuro Duo / Neuro Pro 2): Currently has the strongest research pedigree. Multiple peer-reviewed studies — including the NCAA neuroprotection study and the long COVID brain fog trial — used Vielight devices. Delivers 810nm NIR pulsed at either 40 Hz (Gamma mode, for cognition and focus) or 10 Hz (Alpha mode, for relaxation and sleep). Includes both transcranial and intranasal applicators. The Neuro Pro 2 adds 12 independently adjustable LED modules, cross-frequency coupling, and full app-based customization — designed for clinicians and advanced users. This is the device family with the most published clinical data behind it. Price ranges from $1,799 (single mode) to $5,000+ (Pro 2).

Neuronic Neuradiant 1070: Takes a different approach with a 1070nm wavelength — deeper in the near-infrared spectrum than the 810nm used by Vielight. The rationale is that longer wavelengths may penetrate tissue differently. This is a helmet-style device. The research base for 1070nm specifically is smaller than for 810nm, but the mechanistic rationale is reasonable. A good option for someone interested in exploring wavelength diversity as part of a broader protocol.

iMediSync iSyncWave: A fundamentally different proposition. This device combines PBM with real-time QEEG brain mapping, allowing treatment to be guided by your brain's actual electrical activity. This is the direction I find most exciting — personalized PBM informed by objective brain data. It's also the most expensive and most complex option, positioned for clinical use rather than consumer self-treatment.

Disclosure: I am an affiliate for Vielight (discount code "Greymatters" for 10% off) and Neuronic (checkout code "TotalNeuroSolutions"). I use a Vielight Duo and MIP intranasal personally, and I have used a Neuronic 1070 in clinical settings. The iMediSync is not an affiliate product. My comparisons are based on published specifications, research data, and personal experience where applicable.

[Go to Tools We Trust page for full product listings]

-----

Q8. Is photobiomodulation scientifically proven? What the 2025–2026 research shows.

"Scientifically proven" is a phrase I'm cautious with — because in health technology, it's usually a marketing shortcut rather than an accurate statement. What I can tell you is where the evidence stands as of early 2026, and it's considerably stronger than even a year ago.

Systematic reviews and meta-analyses: A 2025 umbrella review — a review of reviews — analyzed the entire body of randomized controlled trial evidence for PBM across multiple conditions. The findings confirmed statistically significant benefits for pain reduction, tissue repair, and several other applications. These aren't individual studies — they're analyses of the entire body of trial evidence.

Formal clinical guidelines: In 2025, a panel of 21 international experts published the first clinical practice guidelines for PBM. Their consensus: PBM is a safe treatment modality for adults, red light PBM does not induce DNA damage, and the evidence supports clinical use across multiple conditions. This is significant — guidelines signal that a field has matured to the point where the evidence is sufficient for expert consensus.

Brain-specific evidence: The NCAA neuroprotection study (2026) showed transcranial PBM stabilized brain markers during a football season. A sham-controlled pilot trial for long COVID brain fog (2026, published in The Lancet's eClinicalMedicine) showed cognitive improvements. A 2025 crossover trial for mild TBI showed improvements in working memory, post-concussion symptoms, and PTSD scores. A systematic review of all tPBM trials for TBI cognitive outcomes found improvements across the board.

What the evidence doesn't support: The sweeping claims you'll see on device company websites — that PBM is "scientifically proven" to treat dozens of conditions based on cell culture or animal studies. A petri dish study showing increased ATP production does not prove a consumer panel will improve your brain function. A mouse study doesn't translate directly to human dosing. And citing NASA research from the 1990s to sell a wellness panel in 2026 is a credibility stretch, not a proof point.

The honest summary: PBM is guideline-supported, evidence-backed, and the research base is growing rapidly — particularly for brain health applications. It is not a miracle cure, and the gap between what the science shows and what the marketing claims remains wide.

-----

Q9. What should I look for when choosing a PBM device?

Before you compare brands, decide what you're using PBM for. The application determines the device category, and the device category determines what specifications matter.

For skin, muscle, and general wellness (panel devices):

• Wavelength: Look for a combination of red (~630–660nm) and near-infrared (~810–850nm)

• Irradiance: Published power density at the treatment surface, measured in mW/cm². Higher isn't automatically better — remember the biphasic dose response — but the number should be transparent and verifiable

• Treatment area: Matches the body regions you intend to treat

• Third-party testing: Reputable companies provide independent verification of their light output claims

For brain health (transcranial devices):

• Wavelength: 810nm is the most researched for brain applications; 1070nm is an emerging alternative

• Pulsing frequency: 40 Hz (gamma) for cognition and focus; 10 Hz (alpha) for relaxation — supported by different research lines

• Applicator placement: Targets specific brain regions or networks, not random scalp coverage

• Published research: Has the device itself — or its specific parameters — been used in peer-reviewed studies?

• Intranasal component: Some devices include intranasal delivery, which reaches brain regions accessible via nasal vasculature

Red flags to watch for:

• "FDA approved" claims without a clearance number (most are "general wellness" devices — a legitimate category, but not the same as FDA clearance for a medical indication)

• "NASA-tested" as a primary selling point

• Claims based only on cell culture or animal studies

• No published specifications for wavelength, power density, or pulsing parameters

• No return policy or satisfaction guarantee

-----

Q10. Can photobiomodulation help with concussion and traumatic brain injury?

This is the area of PBM research that I follow most closely — for professional reasons and personal ones. As someone with at least six concussions, I have more than an academic interest in this question.

The evidence is meaningful and growing. Here's what we know as of early 2026:

The Lindsey et al. neuroprotection study (2026) followed NCAA football players through a full competitive season. Players receiving real transcranial PBM three times weekly showed stabilized brain markers on MRI, while the sham group showed expected deterioration from sub-concussive impacts. This is the first study to evaluate PBM not just as treatment after injury, but as protection during ongoing exposure — a significant conceptual shift.

A 2025 sham-controlled crossover trial in mild TBI patients showed significant improvements in visual working memory, verbal learning, sleep quality, post-concussion symptoms, and PTSD scores after transcranial PBM compared to sham.

Case series from Margaret Naeser's group at the VA Boston Healthcare System have shown cognitive and mood improvements — including improved connectivity on functional MRI — in ex-football players meeting criteria for possible chronic traumatic encephalopathy.

A 2024 systematic review of all available clinical trials of transcranial PBM for TBI cognitive outcomes found improvements across the board, while noting heterogeneity in protocols and the ongoing need for larger RCTs.

The mechanistic rationale is strong: PBM reduces neuroinflammatory signaling, enhances mitochondrial function, increases cerebral blood flow, and facilitates neuroplasticity — the same biological pathways disrupted by traumatic brain injury.

The honest caveats: sample sizes in brain studies are still modest. The dose-response relationship isn't fully established, and age-related factors complicate how much light reaches the brain in older adults. We need larger RCTs, and we need them across a broader range of TBI severity and chronicity.

But as someone who took hits to the head for decades before anyone offered anything beyond "rest and wait" — this line of research matters. PBM for brain injury has moved from scattered case reports to sham-controlled trials and systematic reviews. That's real progress.

When you are using as many therapies as I do, it can sometimes be difficult to know where the most benefit is derived. Here's what I can honestly say... for the past month, I have only been using PBM therapy-No neurofeedback, no STIM, No brain specific PEMF. My sleep has improved (7-8 hours without waking), and my printing has improved (letters all the same size, no extra 'tail' on letters).

Long COVID & Brain Health

10 questions coming soon — covering what COVID does to the brain, treatment options, neurofeedback for brain fog, and how to evaluate Long COVID treatment providers.